TY - CHAP A1 - Middel, Luise A1 - Palm, Christoph A1 - Erdt, Marius T1 - Synthesis of Medical Images Using GANs T2 - Uncertainty for safe utilization of machine learning in medical imaging and clinical image-based procedures. First International Workshop, UNSURE 2019, and 8th International Workshop, CLIP 2019, held in conjunction with MICCAI 2019, Shenzhen, China, October 17, 2019 N2 - The success of artificial intelligence in medicine is based on the need for large amounts of high quality training data. Sharing of medical image data, however, is often restricted by laws such as doctor-patient confidentiality. Although there are publicly available medical datasets, their quality and quantity are often low. Moreover, datasets are often imbalanced and only represent a fraction of the images generated in hospitals or clinics and can thus usually only be used as training data for specific problems. The introduction of generative adversarial networks (GANs) provides a mean to generate artificial images by training two convolutional networks. This paper proposes a method which uses GANs trained on medical images in order to generate a large number of artificial images that could be used to train other artificial intelligence algorithms. This work is a first step towards alleviating data privacy concerns and being able to publicly share data that still contains a substantial amount of the information in the original private data. The method has been evaluated on several public datasets and quantitative and qualitative tests showing promising results. KW - Neuronale Netze KW - Deep Learning KW - Generative adversarial networks KW - Machine Learning KW - Artificial Intelligence KW - Data privacy KW - Deep Learning KW - Bilderzeugung KW - Datenschutz Y1 - 2019 SN - 978-3-030-32688-3 U6 - https://doi.org/10.1007/978-3-030-32689-0_13 SN - 0302-9743 SP - 125 EP - 134 PB - Springer Nature CY - Cham ER - TY - JOUR A1 - Arribas, Julia A1 - Antonelli, Giulio A1 - Frazzoni, Leonardo A1 - Fuccio, Lorenzo A1 - Ebigbo, Alanna A1 - van der Sommen, Fons A1 - Ghatwary, Noha A1 - Palm, Christoph A1 - Coimbra, Miguel A1 - Renna, Francesco A1 - Bergman, Jacques J.G.H.M. A1 - Sharma, Prateek A1 - Messmann, Helmut A1 - Hassan, Cesare A1 - Dinis-Ribeiro, Mario J. T1 - Standalone performance of artificial intelligence for upper GI neoplasia: a meta-analysis JF - Gut N2 - Objective: Artificial intelligence (AI) may reduce underdiagnosed or overlooked upper GI (UGI) neoplastic and preneoplastic conditions, due to subtle appearance and low disease prevalence. Only disease-specific AI performances have been reported, generating uncertainty on its clinical value. Design: We searched PubMed, Embase and Scopus until July 2020, for studies on the diagnostic performance of AI in detection and characterisation of UGI lesions. Primary outcomes were pooled diagnostic accuracy, sensitivity and specificity of AI. Secondary outcomes were pooled positive (PPV) and negative (NPV) predictive values. We calculated pooled proportion rates (%), designed summary receiving operating characteristic curves with respective area under the curves (AUCs) and performed metaregression and sensitivity analysis. Results: Overall, 19 studies on detection of oesophageal squamous cell neoplasia (ESCN) or Barrett's esophagus-related neoplasia (BERN) or gastric adenocarcinoma (GCA) were included with 218, 445, 453 patients and 7976, 2340, 13 562 images, respectively. AI-sensitivity/specificity/PPV/NPV/positive likelihood ratio/negative likelihood ratio for UGI neoplasia detection were 90% (CI 85% to 94%)/89% (CI 85% to 92%)/87% (CI 83% to 91%)/91% (CI 87% to 94%)/8.2 (CI 5.7 to 11.7)/0.111 (CI 0.071 to 0.175), respectively, with an overall AUC of 0.95 (CI 0.93 to 0.97). No difference in AI performance across ESCN, BERN and GCA was found, AUC being 0.94 (CI 0.52 to 0.99), 0.96 (CI 0.95 to 0.98), 0.93 (CI 0.83 to 0.99), respectively. Overall, study quality was low, with high risk of selection bias. No significant publication bias was found. Conclusion: We found a high overall AI accuracy for the diagnosis of any neoplastic lesion of the UGI tract that was independent of the underlying condition. This may be expected to substantially reduce the miss rate of precancerous lesions and early cancer when implemented in clinical practice. KW - Artificial Intelligence Y1 - 2021 U6 - https://doi.org/10.1136/gutjnl-2020-321922 VL - 70 IS - 8 SP - 1458 EP - 1468 PB - BMJ CY - London ER -